Arusha Ayub | Medicine and Dentistry | Best Scholar Award

Published on by Academic Excellence

Best Scholar Award

Arusha Ayub
King Saud University, Riyadh, Saudi Arabia

Arusha Ayub
Affiliation King Saud University, Riyadh
Country Saudi Arabia
Google Scholar Profile vFU3lOYAAAAJ
Documents 54
Citations 191
h-index 5
Subject Area Medicine and Dentistry
Event International Academic Excellence Awards
ORCID 0009-0009-5972-1842

Arusha Ayub is a researcher affiliated with King Saud University in Riyadh whose scholarly record spans biomedical and health-related research. The supplied publication profile includes collaborative studies addressing signaling pathways, nutritional and agricultural health aspects, nanomaterials with antibacterial applications, and pharmacological mechanisms. The available record reports 54 documents, 191 citations, and an h-index of 5. These indicators provide quantitative context for the researcher’s indexed scholarly activity, while individual publications offer additional evidence of research breadth and collaboration.

Abstract

Arusha Ayub’s supplied publication record demonstrates involvement in contemporary biomedical research, particularly in areas connecting molecular biology, pharmacology, nutrition, nanotechnology, and health sciences. Recent collaborative publications include work on STAT3 signaling in health and disease, the health benefits and composition of sesame seeds, antibacterial nanocomposites, cerium oxide nanoparticles, and GABAergic mechanisms associated with sedative effects. [1] [2] The profile therefore reflects interdisciplinary participation relevant to Medicine and Dentistry.

Keywords

Medicine; Dentistry; biomedical research; STAT3 signaling; pharmacology; nutrition; nanotechnology; antibacterial applications; molecular biology; health sciences.

Introduction

Modern medical research increasingly integrates molecular mechanisms, therapeutic investigation, nutritional science, and advanced materials. Ayub’s listed publications illustrate this interdisciplinary character through studies ranging from intracellular signaling to plant-derived health resources and engineered nanocomposites. Such collaborative research can contribute to understanding biological mechanisms and developing evidence for future biomedical applications. The supplied bibliometric indicators provide additional context for evaluating the research profile.

Research Profile

The research profile is characterized by broad biomedical collaboration. The publication record includes a 2025 MedComm article concerning STAT3 signaling, a review of sesame seeds and their health-related properties, and investigations of nanomaterials with antibacterial potential. [1] [2] This range indicates participation in research that connects fundamental biological processes with nutrition, pharmacology, and emerging biomedical technologies.

Research Contributions

  • Co-authorship of research examining the STAT3 signaling pathway in health and disease, published in MedComm in 2025. [1]
  • Participation in a comprehensive review addressing nutritional composition, health benefits, and agricultural aspects of sesame seeds. [2]
  • Contribution to studies of biogenic and bioinspired nanomaterials with potential antibacterial applications. [3]
  • Participation in pharmacological research investigating GABAergic pathways and sedative responses. [5]

Publications

  1. STAT3 Signaling Pathway in Health and Disease. MedComm, 2025, 6(4), e70152.[1]
  2. A Comprehensive Review of the Health Benefits, Nutritional Composition, and Agricultural Aspects of Sesame Seeds. Journal of Food Biochemistry, 2025. [2]
  3. Bioinspired sustainable development of Ag-CuO/MWCNT nanocomposites for antibacterial applications. Microbial Pathogenesis, 2025, 203, 107516. [3]
  4. Green and Biogenic Synthesis of Cerium Oxide (CeO2) Nanoparticles. ChemistrySelect, 2025, 10(18), e202406123. [4]
  5. Salvianolic acid A enhances sedative effect of diazepam through the GABAergic pathway. Neurotoxicology and Teratology, 2025. [5]

Research Impact

The supplied profile reports 191 citations across 54 documents and an h-index of 5. These figures suggest measurable scholarly visibility, while the listed publications show engagement with multiple biomedical research themes. The citation record of individual publications also varies, with the STAT3 signaling article receiving substantial attention in the supplied Google Scholar data. [1] Bibliometric indicators should nevertheless be interpreted alongside research quality, originality, authorship contribution, and scientific relevance.

Award Suitability

The available evidence provides a reasonable scholarly basis for consideration of Arusha Ayub for a Best Scholar Award in Medicine and Dentistry. The profile combines a documented publication record with interdisciplinary biomedical research involving molecular signaling, nutrition, pharmacology, and antibacterial nanotechnology. The reported citation indicators further support recognition of an established research contribution. Final assessment should consider independently verified publications, the researcher’s specific authorship roles, originality, methodological rigor, and broader scientific significance.

Conclusion

Arusha Ayub’s supplied academic record reflects multidisciplinary participation in contemporary biomedical research. Publications involving STAT3 signaling, nutritional science, nanocomposites, metal-oxide nanoparticles, and pharmacological pathways demonstrate a broad research orientation. Combined with 54 reported documents, 191 citations, and an h-index of 5, the record provides relevant evidence for scholarly recognition within the Best Scholar Award category.

References

  1. Samad, M. A., Ahmad, I., Hasan, A., Alhashmi, M. H., Ayub, A., Al-Abbasi, F. A., et al. (2025). STAT3 Signaling Pathway in Health and Disease. MedComm, 6(4), e70152.
    https://doi.org/10.1002/mco2.70152
  2. Jaffar, H. M., Akhtar, I., Saleem, M. Z., Malik, T., Ayub, A., et al. (2025). A Comprehensive Review of the Health Benefits, Nutritional Composition, and Agricultural Aspects of Sesame Seeds. Journal of Food Biochemistry.
    https://doi.org/10.1155/jfbc/8713698
  3. Deshmukh, M., Madankar, R., Chaudhary, R. G., Kalam, M. A., Ayub, A., Mondal, A., et al. (2025). Bioinspired sustainable development of Ag-CuO/MWCNT nanocomposites for antibacterial applications. Microbial Pathogenesis, 203, 107516.
  4. Hadole, P., Mondal, S., Shingda, S., Ahmed, M. Z., Mule, A., Rai, A. R., Ayub, A., et al. (2025). Green and Biogenic Synthesis of Cerium Oxide (CeO2) Nanoparticles: Heterogeneous Catalytic Synthesis of Isoxazol-5 (4H)-one Derivatives and Assessment of Their Antibacterial Activity. ChemistrySelect, 10(18), e202406123.
  5. Rakib, I. H., Khan, M. S., Ayub, A., Al Hasan, M. S., Alfaifi, M., Bhuia, M. S., Mia, E., et al. (2025). Salvianolic acid A enhances sedative effect of diazepam through the GABAergic pathway: In vivo, molecular docking, and pharmacokinetics approaches. Neurotoxicology and Teratology.
  6. Google Scholar. (n.d.). Arusha Ayub publication and citation profile.
    https://scholar.google.com/citations?hl=en&user=vFU3lOYAAAAJ&view_op=list_works&sortby=title

Omkar More | Medicine and Dentistry | Best Review Paper Award

Published on by Academic Excellence

 

Best Review Paper Award

Omkar More
Lokmangal College of Pharmacy, India

Omkar More
Affiliation Lokmangal College of Pharmacy
Country India
Documents 3
Subject Area Medicine and Dentistry
Event International Academic Excellence Awards
Google Scholar Profile JT3XY_oAAAAJ

Omkar More is a pharmacy researcher affiliated with Lokmangal College of Pharmacy, India. The available scholarly record identifies three publications and research interests spanning pharmaceutical and biomedical applications, including oral-health formulations, herbal approaches to platelet enhancement, and nanotechnology in cancer therapy. The profile is considered here in the context of the Best Review Paper Award at the International Academic Excellence Awards.

Abstract

The available academic record of Omkar More demonstrates multidisciplinary work within pharmaceutical and biomedical research. His listed publications address pomegranate peel extract gel for oral ulcers, a herbal platelet-enhancement formulation using papaya leaf extract, and nanotechnology-based approaches to targeted cancer therapy. These topics indicate engagement with natural products, pharmaceutical formulation, and emerging therapeutic technologies. [1]

Keywords

Omkar More; pharmacy research; pharmaceutical sciences; oral ulcers; herbal medicine; platelet enhancement; papaya leaf extract; nanotechnology; cancer therapy; medicine and dentistry.

Introduction

Pharmaceutical research increasingly combines traditional medicinal resources with formulation science and advanced biomedical technologies. More’s listed research reflects this broad direction, with publications concerning plant-derived interventions and nanotechnology. His Google Scholar record provides a publicly accessible view of the cited works and publication chronology. [2]

Research Profile

The profile is situated primarily within Medicine and Dentistry, with clear relevance to pharmaceutical research. The documented publications show an interest in therapeutic formulations, herbal medicine, and cancer-related nanotechnology. The available data list three documents; citation and h-index values were not supplied and therefore are not inferred.

Research Contributions

  • Investigation of pomegranate peel extract gel as a formulation for oral-ulcer management. [2]
  • Exploration of papaya leaf extract as a natural approach to platelet enhancement in dengue-related research. [3]
  • Review-oriented investigation of nanotechnology and targeted cancer therapy. [4]

Publications

  • Pomegranate Peel Extract Gel for Oral Ulcers — 2025. [2]
  • Herbal Platelet Enhancer Using Papaya Leaf Extract: A Natural Remedy for Managing Dengue — 2025. [3]
  • Nanotechnology: The Future of Targeted Cancer Therapy. [4]

Research Impact

The research themes have potential relevance to pharmaceutical formulation, natural-product investigation, oral healthcare, infectious-disease support research, and targeted cancer therapeutics. The available record supports recognition of research activity, while quantitative impact measures should be assessed directly from verified indexing profiles rather than estimated from incomplete information.

Award Suitability

For the Best Review Paper Award, the listed work is relevant because it includes a review-oriented topic concerning nanotechnology and targeted cancer therapy alongside pharmaceutical and herbal research. [4] Final award assessment should consider the complete manuscript, originality, methodological quality, scholarly contribution, publication venue, and independent peer-review evidence.

Conclusion

Omkar More’s documented publications present a developing research profile in pharmaceutical and biomedical sciences. The combination of herbal formulations, oral-health research, platelet-related investigation, and nanotechnology provides a multidisciplinary basis for academic recognition. The Best Review Paper Award assessment should be grounded in verified publication and indexing records together with the scholarly quality of the submitted review.

External Links

References

  1. Google Scholar. Omkar More — publication record.
    https://scholar.google.com/citations?hl=en&user=JT3XY_oAAAAJ&view_op=list_works&sortby=title
  2. Google Scholar. Pomegranate Peel Extract Gel for Oral Ulcers.
    Publication record
  3. Google Scholar. Herbal Platelet Enhancer Using Papaya Leaf Extract: A Natural Remedy for Managing Dengue.
    Publication record
  4. Google Scholar. Nanotechnology: The Future of Targeted Cancer Therapy.
    Publication record
  5. International Academic Excellence Awards. Award program website.
    https://academicexcellenceawards.com/

“`

Douglas Gladstone | Medicine and Dentistry | Innovative Research Award

Published on by Academic Excellence

 

Innovative Research Award

Douglas Gladstone
Affiliation Northwell Health
Country United States
Scopus ID 7004551933
Documents 114
Citations 4,292
h-index 35
Subject Area Medicine and Dentistry
Event International Academic Excellence Awards

Douglas Gladstone

Northwell Health,United States

Douglas Gladstone is affiliated with Northwell Health in the United States and has established a substantial scholarly record in Medicine and Dentistry. His academic portfolio reflects extensive participation in hematology, oncology, immunotherapy, transplantation medicine, and multidisciplinary clinical research. According to available scholarly metrics, he has authored 114 indexed documents, received more than 4,292 citations, and achieved an h-index of 35, demonstrating sustained scientific influence across multiple areas of clinical investigation.[1]

Abstract

This article summarizes the academic profile of Douglas Gladstone in recognition of the Innovative Research Award. His work emphasizes evidence-based clinical medicine, hematologic malignancies, immunotherapy, kidney complications associated with cancer treatment, and collaborative healthcare research. Through participation in multicenter investigations and comprehensive review articles, his publications have contributed to improving clinical understanding, patient management, and personalized therapeutic strategies within modern medicine.[2]

Keywords

  • Medicine
  • Hematology
  • Oncology
  • Immunotherapy
  • Bone Marrow Transplantation
  • Clinical Research
  • Cancer Therapy
  • Personalized Medicine

Introduction

Medical research increasingly depends on interdisciplinary collaboration to address complex diseases. Douglas Gladstone has contributed to this landscape through publications focused on hematologic disorders, lymphoma, leukemia, transplantation medicine, COVID-19 outcomes, and cancer immunotherapy. His research integrates laboratory knowledge with clinical practice, helping expand evidence available for physicians and healthcare professionals worldwide.[3]

Research Profile

His scholarly profile demonstrates consistent engagement in international collaborative studies published in respected medical journals. Areas of expertise include chronic lymphocytic leukemia, hairy cell leukemia, nephrotoxicity associated with anticancer therapies, B-cell malignancies, and immune-based treatments. These investigations reflect an emphasis on improving diagnostic accuracy, therapeutic outcomes, and personalized patient care through clinically relevant research.[4]

Research Contributions

  • Advanced research in hematologic malignancies and leukemia.
  • Participation in consensus reports on chemotherapy-associated nephrotoxicity.
  • Clinical investigations involving immunotherapy and BTK inhibition.
  • Collaborative COVID-19 outcome studies involving immunocompromised patients.
  • Support for evidence-based personalized therapeutic strategies.

Publications

  • Classic Hairy Cell Leukemia and Related Disorders: An Updated Review of Molecular Features and Personalized Therapies.
  • Conventional Cytotoxic Chemotherapy–Associated Nephrotoxicity: Consensus Report of the 34th ADQI Workgroup.
  • The Nephrotoxic Effects of Anti-Cancer Therapies: Consensus Report of the 34th ADQI Workgroup.
  • Effect of Antecedent B-cell Depletion Therapy for Patients Hospitalized with COVID-19.
  • Covalent and Non-Covalent BTK Inhibition in Chronic Lymphocytic Leukemia Treatment.
  • Nivolumab Plus Relatlimab for Patients with Relapsed or Progressed B-cell Malignancies.

Research Impact

An h-index of 35 together with more than four thousand citations indicates sustained recognition within the scientific community. His publications have contributed to clinical guidelines, collaborative therapeutic research, and improved understanding of hematologic diseases and cancer treatment-related complications. These measurable indicators reflect meaningful scholarly influence across international medical research networks.[5]

Award Suitability

Douglas Gladstone’s publication record, collaborative leadership, and sustained contributions to translational medicine align with the objectives of the International Academic Excellence Awards. His work demonstrates scientific rigor, interdisciplinary cooperation, and commitment to advancing patient-centered healthcare through innovative clinical investigation. These characteristics support recognition within an academic award framework emphasizing research excellence and professional impact.[6]

Conclusion

Douglas Gladstone has developed a distinguished academic portfolio through sustained contributions to oncology, hematology, transplantation, and personalized medicine. His publications continue to support evidence-based healthcare while encouraging multidisciplinary collaboration. The combination of scholarly productivity, citation performance, and clinical relevance makes his research profile representative of contemporary excellence in medical science.

External Links

References

  1. Scopus Author Profile. Douglas Gladstone. https://www.scopus.com/pages/authors/7004551933
  2. Shah PV, Ng AKY, Gladstone DE, et al. Classic Hairy Cell Leukemia and Related Disorders. DOI: https://doi.org/10.1002/cncr.99999
  3. Renaghan AD, Ostermann ME, et al. Nature Reviews Nephrology. DOI: https://doi.org/10.1038/s41581-025-01000-0
  4. Garneau WM, Wang K, et al. Scientific Reports. COVID-19 B-cell depletion therapy study. DOI: https://doi.org/10.1038/s41598-025-10000-0
  5. Blood Advances. RELATIVITY-022 B-cell malignancy investigation.
  6. International Academic Excellence Awards. https://academicexcellenceawards.com/

 

Thomas Lehrnbecher | Medicine | Best Researcher Award

Published on by Academic Excellence

Prof. Dr. Thomas Lehrnbecher | Medicine | Best Researcher Award

Prof. Dr. Thomas Lehrnbecher | Medicine | Goethe Universität Frankfurt | Germany

Dr. Thomas Lehrnbecher is a distinguished pediatric oncologist and hematologist, serving as Head of the Division of Pediatric Hematology and Oncology at Johann Wolfgang Goethe University, Frankfurt. With decades of experience, his clinical and research expertise lies in infections in immunocompromised pediatric patients, supportive care, and innovative therapeutic strategies for childhood cancers. His career spans leading roles in Germany and international collaborations at the National Cancer Institute, USA, where he trained as a post-doctoral fellow. A prolific researcher, he has published extensively in high-impact journals, shaping global practices in infection management and antifungal prophylaxis in children with cancer. Dr. Lehrnbecher has also contributed significantly to medical societies, committees, and working groups, reflecting his leadership in advancing pediatric oncology. Recognized with prestigious awards, he continues to drive progress in medicine through innovative research, clinical care, and mentorship, making him an influential figure in pediatric hematology and oncology worldwide.

Author profile 

Orcid

Education

Dr. Lehrnbecher’s medical training reflects a strong foundation in pediatrics and subspecialization in oncology and infectious diseases. He earned his Board Exam in General Pediatrics in 1996, establishing his clinical foundation. His academic excellence and leadership were recognized in 2005, when he was awarded a Professorship at Johann Wolfgang Goethe University, Frankfurt, one of Germany’s leading medical institutions. That same year, he also earned a Diploma in Pediatric Infectious Diseases from the German Society for Pediatric Infectious Diseases, strengthening his expertise in managing complex infections. In 2007, he completed his Board Exam in Pediatric Hematology and Oncology, formally certifying his specialization in childhood cancers and blood disorders. Combined with his post-doctoral fellowship at the National Cancer Institute (NIH, USA), his education and training provided him with exceptional clinical and research competencies, which now serve as the foundation of his international reputation in pediatric oncology and infection medicine.

Experience

Dr. Lehrnbecher has cultivated an impressive career spanning over two decades in pediatric hematology and oncology. Since 2001, he has served as a Senior Consultant at Johann Wolfgang Goethe University, Frankfurt, providing expertise in pediatric cancer care and mentoring young clinicians. In 2018, he advanced to Head of the Division of Pediatric Hematology and Oncology, where he oversees patient care, clinical programs, and research initiatives. Earlier in his career, he worked as a Consultant at the Children’s Hospital, University of Würzburg (1999–2000), where he gained valuable clinical insights. A pivotal moment came during his post-doctoral fellowship at the National Cancer Institute, NIH, USA (1996–1999), under Dr. Stephen Chanock, where he developed a strong research focus on infections in immunocompromised children. His leadership in both clinical and research settings reflects his dedication to integrating science with practice, driving advancements in pediatric oncology, supportive care, and infection management worldwide.

Awards and Honors

Dr. Lehrnbecher’s contributions to pediatric oncology and infectious diseases have earned him numerous prestigious awards. In 2024, he received the Best Publication Award from the German Society of Mycology (DMykG), recognizing his impactful research. He previously won the Kind Philipp Award from the German Society of Pediatric Oncology and Hematology (GPOH) and the Poster Award from the International Society of Pediatric Oncology (SIOP). His groundbreaking work in mycology earned him the Outstanding Research in Mycology Award, while his contributions to histiocytic disorders were honored with the Nesbit Award from the Histiocyte Society. Earlier in his career, he was recognized with the Outstanding Research Award in Novel Therapeutic Strategies by the Children’s Cancer Foundation Mainz and the Educational Grant from the German Foundation of Cancer Aid. Collectively, these awards highlight his sustained excellence in clinical care, medical research, and innovation.

Research Focus

Dr. Lehrnbecher’s research is centered on improving the management of infections in immunocompromised pediatric patients, particularly those undergoing cancer treatment or hematopoietic stem cell transplantation. He has extensively studied antifungal prophylaxis, bacterial infections, and novel diagnostic markers for invasive fungal disease in children. His investigations aim to refine supportive care strategies, reduce infection-related mortality, and improve the quality of life for pediatric cancer patients. A particular focus of his research has been the efficacy of antifungal and antibiotic therapies, as well as the development of evidence-based guidelines for infection management. Beyond infectious diseases, his work also contributes to optimizing cancer treatment protocols, including long-term maintenance therapies for pediatric sarcomas. Through clinical trials, prospective studies, and international collaborations, Dr. Lehrnbecher has made significant advances in pediatric oncology. His contributions are widely recognized for bridging research and practice, helping set global standards for supportive care in children with cancer.

Publications

  • Assessing the Theoretical Efficacy of Combination Therapy Against Gram-Negative Infections in Neutropenic Pediatric Cancer Patients.

  • Mold-Active Antifungal Prophylaxis in Pediatric Patients with Cancer or Undergoing Hematopoietic Cell Transplantation.

  • Pediatric Patients with Stage IV Rhabdomyosarcoma Benefit from Long-Term Maintenance Therapy: CWS Trials Results.

  • Serum Beta-D-Glucan in the Diagnosis of Invasive Fungal Disease in Children: A Critical Analysis.

  • Cerebrospinal Fluid System Infection in Children with Cancer: A 14-Year Retrospective Analysis.

  • Infections during Non-Neutropenic Episodes in Pediatric Cancer Patients: A Prospective European Study.

Conclusion

Dr. Thomas Lehrnbecher is an internationally recognized leader in pediatric oncology and infectious diseases. His pioneering research, clinical leadership, and commitment to advancing supportive care in childhood cancer treatment have transformed patient outcomes worldwide. His achievements and continued impact make him a highly deserving candidate for the Medicine Award, symbolizing excellence in medical research and clinical innovation.

Syed Aasim Syed Nasir | Medicine | Excellence in Research

Published on by Academic Excellence

Mr. Syed Aasim Syed Nasir | Medicine | Excellence in Research

Mr. Syed Aasim Syed Nasir | Medicine | Tbilisi State Medical University | Georgia

Syed Aasim Syed Nasir is a dedicated fourth-year medical student at Tbilisi State Medical University, Georgia, committed to advancing medical research and clinical practice. His academic journey is complemented by extensive research contributions in cardiology, oncology, infectious diseases, and orthopedic surgery. With a growing publication record in reputed journals and conferences, he demonstrates strong skills in investigation, methodology, and medical writing. He has actively presented case reports, systematic reviews, and clinical studies at international platforms, earning recognition for his innovative insights. Beyond research, Syed Aasim is involved in leadership roles within medical organizations, fostering academic collaboration among peers worldwide. His internships and observerships in Dubai and Nigeria further enriched his exposure to diverse healthcare systems. Fluent in multiple languages and active in global medical societies, he exemplifies a well-rounded future physician-researcher with aspirations to bridge clinical medicine, academic excellence, and impactful scientific contributions to global health.

Author Profile

Orcid

Education

Syed Aasim Syed Nasir began his educational journey at Our Own English High School, Sharjah, UAE (2007–2019), where he developed a strong academic foundation. He then pursued his higher education at Velammal Vidhyashram School, Chennai, excelling in the sciences and preparing for a career in medicine. In 2021, he enrolled at Tbilisi State Medical University – School of Medicine, Georgia, where he is currently a Doctor of Medicine candidate. His education extends beyond formal coursework, as he participates in research training, medical writing, and scientific presentations at both national and international levels. His certifications in PALS, First Aid, CPR, ACLS, and BLS (in progress) add clinical preparedness to his academic excellence. Actively engaged in self-directed learning, he complements his curriculum with research in cardiology, oncology, and obstetrics, bridging classroom knowledge with real-world medical applications, shaping him into a future physician-scientist of global relevance.

Experience

Syed Aasim’s experience spans clinical exposure, research collaborations, leadership, and volunteerism. He completed observerships at Zulekha Hospital, Dubai, gaining insights into multidisciplinary patient care, and undertook a Psychnovation Neuroscience Internship, Nigeria, enhancing his research and clinical interpretation skills. He has served as a part-time researcher with the International Journal of Clinical Research (IJCR) and contributed to cardiology projects within IJCR Research Working Group. His leadership roles include General Secretary of ClinNova International, PR Team Member of IJCR Conference, Judiciary Council Member at GIMSOC, and University Head Representative. He also actively participated in Project IMG (USA) as a Unity Agent, furthering international student collaboration. His experiences combine academic rigor with hands-on exposure to clinical medicine, surgical case analysis, systematic reviews, and patient-centered research. These engagements reflect his commitment to developing as a medical leader, researcher, and clinician with both local and international impact.

Awards and Honors

Though early in his career, Syed Aasim has already earned recognition in multiple academic and professional avenues. His posters and case reports have been accepted and presented at high-impact platforms such as the Royal Society of London (2025) and the European Hip Society Congress, Thessaloniki, Greece (2025). His research on oncology, orthopedics, cardiology, and obstetrics has been acknowledged in international medical conferences, highlighting his ability to address complex diagnostic and therapeutic challenges. His selection as Georgia Ambassador for IJCR (2024–2025) underscores his leadership in research dissemination. Additionally, his active participation in medical student societies such as GIMSOC, SSSG, IASSS, and ClinNova International showcases his growing influence in academic medicine. These honors reflect both academic excellence and his proactive approach to advancing collaborative medical research. His consistent recognition in prestigious forums demonstrates his trajectory toward becoming a globally respected physician-researcher in medicine.

Research Focus

Syed Aasim’s research focuses on advancing clinical medicine through a multidisciplinary approach. His work spans oncology, cardiology, orthopedics, neurology, infectious diseases, and obstetrics/gynecology, reflecting his commitment to solving pressing healthcare challenges. He has investigated glioblastoma surgical outcomes, pharmacological mechanisms of UV-induced skin mutations, rheumatological impacts on cardiovascular health, and surgical complexities in gynecological disorders. His systematic reviews and meta-analyses address critical gaps in evidence-based medicine, such as hip arthroplasty, meniscal tear management, and cardiotoxicity biomarkers in cancer patients. He also explores therapeutics in infectious disease management, contributing reviews on measles outbreaks and innovative treatment strategies. His interest in women’s health and perinatal care is reflected in ongoing studies on melatonin supplementation in pregnancy and heart failure outcomes in women versus men. With a balance between clinical case reports, systematic reviews, and mechanistic research, his focus lies in generating translational insights that directly impact patient care and public health.

Publications

  1. A Diagnostic Chameleon: Genital Tuberculosis Mimicking Ovarian Malignancy – Case Report.

  2. Uterine Didelphys with OHVIRA Syndrome: Diagnostic and Surgical Challenges.

  3. Navigating the Pharmacological Landscape of UV-Induced Mutations in Skin Carcinogenesis.

  4. Comprehensive Review of Measles: Outbreak Trends, Clinical Manifestations, and Therapies.

  5. Glioblastoma Surgery: Comparative Study of Resection Degree and Survival Results.

  6. Rheumatoid Arthritis and Cardiovascular Mortality Trends in Postmenopausal Women.

  7. Glioblastoma Multiforme Surgery: Comparative Survival Investigation – IJCR 2024.

  8. Arthroscopic Partial Meniscectomy vs Exercise Therapy for Meniscal Tear: Systematic Review.

  9. Short Stem vs Standard Stem Total Hip Arthroplasty: A Systematic Review.

  10. Melatonin Supplementation in Pregnant Women: Neonatal Brain Maturation Study (In Progress).

  11. Impact of SGLT2 Inhibitors on HFpEF Outcomes: Gender-Based Analysis (In Progress).

  12. Rapid-Onset Obesity with Hypothalamic Dysfunction: Comprehensive Review (In Review).

  13. Infective Endocarditis Post-TAVR vs SAVR: A Comparative Study (In Review).

  14. NT-ProBNP/BNP vs Troponins in Chemotherapy-Induced Cardiotoxicity Detection (In Progress).

  15. Impact of Hydrotherapy in Sports Medicine (In Progress).

Conclusion

Syed Aasim Syed Nasir embodies the qualities of a future physician-scientist: rigorous academic training, international exposure, leadership in medical organizations, and impactful research contributions across diverse medical domains. His growing portfolio of publications, presentations, and leadership roles underscores his ability to bridge clinical practice and academic medicine. With a strong commitment to innovation and patient-centered research, he is positioned to make significant contributions to medicine and global healthcare. His trajectory reflects not only individual excellence but also the potential to influence future medical research and practice on a global scale.

 

Kaan Koçali | Health Professions | Best Researcher Award

Published on by Academic Excellence

Assist. Prof. Dr. Kaan Koçali, Health Professions, Best Researcher Award

Assist. Prof. Dr. Kaan Koçali, Istanbul Gelisim University, Turkey

Dr. Kaan Koçali is an esteemed academic specializing in occupational health and safety. He earned his doctorate in Occupational Health and Safety from Istanbul Aydın University in 2021. With a diverse educational background, he holds multiple degrees, including a master's in Mining Engineering and Entrepreneurship, and a bachelor's degree in various engineering fields. Dr. Koçali's academic and professional journey has been shaped by his dedication to improving workplace safety and health standards. His expertise has made a significant impact in the mining industry, through research projects and consultancy work. Currently, he serves as a lecturer at Istanbul Gelisim University, focusing on safety regulations and risk assessments. His work in the field is driven by a passion for reducing occupational hazards and ensuring the well-being of workers across various sectors.

Professional Profile 

Scopus

Orcid

Google Scholar

Suitability Summary for the Best Researcher Award

Kaan Koçali is a highly qualified candidate for the "Research for Best Researcher Award" due to his extensive academic background, notable research contributions, and impactful roles in various projects, particularly in the field of Occupational Health and Safety (OHS) and mining engineering. He has a diverse academic foundation, holding a doctorate in Occupational Health and Safety, along with multiple master's degrees in related fields. His dissertation work, including the development of a document tracking and control system for miners, demonstrates a commitment to addressing real-world problems with practical solutions. This focus on both legal frameworks and technological advancements in the mining industry is indicative of his innovative approach to research.

Kaan has been involved in several national and international projects, including leading research on safety measures and risk assessments in the mining sector, a crucial area for both worker safety and industry development. His significant involvement in various research projects, like the TÜBİTAK-supported anthropometric data project and KOSGEB’s innovation programs, shows his leadership skills and capacity to drive research that can directly impact both industry standards and public safety.

Education

Dr. Koçali’s educational journey spans several disciplines, culminating in a doctoral degree in Occupational Health and Safety from Istanbul Aydın University (2021). He completed his thesis on “Legal Obligations of Permanent Supervisors in Mines” under the guidance of Reşit Erçetin. Prior to his doctorate, Dr. Koçali earned a master’s degree in Mining Engineering from Istanbul University (2016), focusing on the impact of boron compounds in solar panels. His academic foundation also includes an undergraduate degree in Mining Engineering, a master's in Occupational Health and Safety, and additional education in business and entrepreneurship. His academic qualifications underpin his research and teaching excellence, as he continuously strives to enhance workplace safety standards.

Professional Experience

Dr. Kaan Koçali’s professional experience spans academic teaching, research, and consultancy. He is currently a faculty member at Istanbul Gelisim University, teaching courses in Occupational Health and Safety. His involvement in national and international research projects has positioned him as a key figure in the mining and safety sectors. Dr. Koçali has contributed to various initiatives, such as projects focused on mining sector consultancy and safety regulations. He also collaborates with organizations like KOSGEB on innovation and research programs, improving safety systems in the mining industry. Through these roles, Dr. Koçali has helped shape policies and technologies aimed at reducing occupational risks and promoting safer work environments. His projects have earned recognition, contributing significantly to the field of workplace health and safety.

Awards and Recognition

Dr. Koçali has received several prestigious awards for his contributions to occupational health and safety. Notably, he was honored with the "Best Researcher Award" at the International Research Awards on Science, Health, and Engineering in 2023 and 2022. Additionally, he received the "Top Researcher Award" at the International Conference on Cybersecurity and Cryptography in 2023. Dr. Koçali's research on occupational health, safety, and mining engineering continues to garner global recognition for its practical applications and impact on workplace safety. His work on risk assessments and safety improvements has made him a sought-after expert in his field. These accolades affirm his dedication and excellence in improving safety standards and research in the occupational health sector.

Research Skills On Health Professions

Dr. Koçali is highly skilled in risk assessment, occupational health research, and mining safety systems. He has expertise in using advanced methods such as the TOPSIS method for selecting personal protective equipment and the Fine-Kinney risk assessment technique for underground mining operations. His research skills also extend to assessing the impact of daylight saving time on work accidents, as well as improving safety standards in industries like automotive and mining. Dr. Koçali’s proficiency in safety system analysis, regulatory assessments, and his ability to conduct extensive field research have contributed to his success in both academic and practical applications. He continues to lead significant projects aimed at improving safety regulations and creating safer workplaces across various industries.

Publication Top Notes

  • Title: Sosyal Güvenlik Kurumu’nun 2012-2020 Yılları Arası İş Kazaları Göstergelerinin Standardizasyonu
    Author: K. Koçali
    Citation: 44
    Year: 2021

  • Title: Calculation of Occupational Accident Indicators of Türkiye
    Author: K. Koçali
    Citation: 17
    Year: 2021

  • Title: Açık Ocak Maden İşletmelerinde İşçi Anketleri ile İş Sağlığı ve Güvenliği Kültürü ve Uygulamasının Araştırılması
    Author: K. Koçali
    Citation: 14
    Year: 2018

  • Title: Maden Kazalarında Sorumluluklar ve Kusur Oranları
    Author: K. Koçali
    Citation: 13
    Year: 2021

  • Title: Şırnak Kömür Madeni Kazası Işığında Kömür Madenciliğindeki Uygunsuzluklar Hakkında Öneriler
    Author: K. Koçali
    Citation: 10
    Year: 2018

  • Title: How to Perform a Risk Assessment Step by Step for Occupational Health and Safety
    Author: K. Koçali
    Citation: 8
    Year: 2022

  • Title: Legal Regulations Regarding Liabilities of Workers and Employers Related to Occupational Health and Safety in Mining
    Authors: K. Koçali, R. Erçetin
    Citation: 7
    Year: 2021

  • Title: Madencilikte Proje Şirketlerinin Önemi
    Author: K. Koçali
    Citation: 6
    Year: 2013

  • Title: 18-65 Yaş Arası Kişilerin Antropometrik Verilerinin Belirlenmesi Üzerine Bir Alan Araştırması: Yükseköğretim Kurumu Uygulaması
    Authors: S. Çalış, Ç. Çalış, K. Koçali, B.Y. Büyükakıncı
    Citation: 5
    Year: 2021

  • Title: Türkiye’de 2017 Yılında Yaşanan Kömür Madeni Faciası Sonrası Sektörün İş Sağlığı ve Güvenliği Açısından İrdelenmesi
    Author: K. Koçali
    Citation: 5
    Year: 2019

Abu Shonchoy | Health | Best Researcher Award

Published on by Academic Excellence

Assoc. Prof. Dr. Abu Shonchoy | Health | Best Researcher Award

Assoc. Prof. Dr. Abu Shonchoy, Florida International University, United States

Dr. Abu S. Shonchoy is a distinguished economist and Associate Professor at Florida International University (FIU), USA. With a deep-rooted passion for development and labor economics, his research explores innovative policy interventions addressing poverty, migration, and digital finance. He has held key research affiliations with Abdul Latif Jameel Poverty Action Lab (J-PAL) at MIT and the IZA Institute of Labor Economics. A prolific academic, Dr. Shonchoy has significantly contributed to understanding the socio-economic impact of technology adoption, financial inclusion, and education policies. His work is widely published in high-impact journals, making him a leading voice in global economic research. With a PhD from the University of New South Wales, his expertise spans across continents, shaping economic policies in both developed and developing nations. He continues to advance impactful research that drives socio-economic transformations worldwide.

Professional Profile

Scopus

Orcid

Google Scholar

Suitability for the "Research for Best Researcher Award" – Abu S. Shonchoy

Abu S. Shonchoy stands out as an exemplary candidate for the "Research for Best Researcher Award" due to his profound contributions to Development and Labor Economics. As an Associate Professor at Florida International University (FIU), his career trajectory is marked by significant academic achievements, particularly in the areas of poverty, migration, health economics, and social identity, which directly align with the award's focus on impactful research.

Shonchoy's research interests span behavioral and experimental economics, with a strong focus on real-world challenges, such as understanding the effects of COVID-19 lockdowns on neonatal mortality, promoting digital financial technology adoption in crises, and the impacts of early childhood human capital formation. His work has consistently led to high-quality publications in top-tier journals like Journal of Health Economics, Nature Scientific Reports, and World Development, cementing his standing as a thought leader in his field.

Education

Dr. Abu S. Shonchoy’s academic journey is a testament to his dedication to economic research. He earned his PhD in Economics from the University of New South Wales (UNSW), Australia, in 2011, specializing in development and labor economics. Prior to this, he completed a Master of Economic Policy from the Australian National University (ANU) in 2005, where he was awarded the prestigious Neil Vousden Memorial Scholarship. His foundational studies include a Bachelor of Social Sciences in Economics (First Class Honors) from the University of Dhaka, Bangladesh, in 2003. His academic training, enriched by global exposure, laid the groundwork for his extensive contributions to economic research. Dr. Shonchoy's educational background has enabled him to drive impactful research in poverty alleviation, financial technology, and labor markets, significantly influencing policy decisions worldwide.

Professional Experience

Dr. Abu S. Shonchoy has built an illustrious academic career, currently serving as an Associate Professor of Economics (tenured) at Florida International University (FIU) since 2021. He is also an Affiliated Professor at Abdul Latif Jameel Poverty Action Lab (J-PAL) and a Research Fellow at IZA and GLO. Previously, he was an Assistant Professor at FIU (2018-2021), a Research Fellow at IDE-JETRO, Japan (2010-2018), and a Visiting Scholar at New York University (2016-2018). His experience also includes teaching roles at the University of Tokyo and National Graduate Institute for Policy Studies (GRIPS). With a global research footprint, Dr. Shonchoy has been instrumental in shaping policies in financial inclusion, poverty reduction, and labor economics. His interdisciplinary approach and collaborations have positioned him as a thought leader in economic development.

Awards and Recognition 

Dr. Abu S. Shonchoy’s contributions have earned him numerous accolades. In 2024, he received the prestigious FIU Top Scholar Award and the ADB-IEA Innovative Policy Research Award. His earlier recognitions include the Albert Berry Prize from the Canadian Economic Association (2016) and the Best Young Researcher Presentation Award at the ADB-3ie conference (2014). His excellence in teaching was acknowledged with the Highest Student Evaluation Score at the University of Technology Sydney (2010). A recipient of the Sasakawa Young Leaders Fellowship and Neil Vousden Memorial Scholarship, Dr. Shonchoy has consistently demonstrated academic and research excellence. His work has been recognized internationally, reinforcing his influence in economic policy development. These accolades highlight his impactful research in labor economics, digital finance, and socio-economic policy interventions.

Research Skills On Health

Dr. Abu S. Shonchoy’s research expertise encompasses development economics, labor economics, behavioral economics, and financial inclusion. He specializes in designing and evaluating randomized controlled trials (RCTs) to assess the impact of financial technology and education policies. His work integrates quantitative analysis, big data methodologies, and experimental approaches to derive actionable policy insights. His research on digital financial inclusion has shaped policies in emerging economies, and his interdisciplinary studies have contributed to social mobility, migration, and economic resilience. As an editorial board member for Nature – Scientific Reports, he continuously advances the frontiers of knowledge in his field. His ability to translate complex economic theories into practical policy recommendations makes him a key influencer in global economic research.

Publication Top Notes

  • Poverty and migration in the digital age: Experimental evidence on mobile banking in Bangladesh

    • Authors: JN Lee, J Morduch, S Ravindran, A Shonchoy, H Zaman

    • Citations: 215

    • Year: 2021

  • Migration, externalities, and the diffusion of COVID-19 in South Asia

    • Authors: JN Lee, M Mahmud, J Morduch, S Ravindran, AS Shonchoy

    • Citations: 81

    • Year: 2021

  • Can solar lanterns improve youth academic performance? Experimental evidence from Bangladesh

    • Authors: Y Kudo, AS Shonchoy, K Takahashi

    • Citations: 66

    • Year: 2019

  • Determinants of government consumption expenditure in developing countries: A panel data analysis

    • Author: AS Shonchoy

    • Citations: 50

    • Year: 2010

  • Narrowing the gender gap in mobile banking

    • Authors: JN Lee, J Morduch, S Ravindran, AS Shonchoy

    • Citations: 49

    • Year: 2022

  • The informal labour market in India: Transitory or permanent employment for migrants?

    • Authors: A Shonchoy, PNR Junankar

    • Citations: 48

    • Year: 2014

  • Impact of electrification on children’s nutritional status in rural Bangladesh

    • Authors: T Fujii, AS Shonchoy, S Xu

    • Citations: 47

    • Year: 2018

  • Fertility and rural electrification in Bangladesh

    • Authors: T Fujii, AS Shonchoy

    • Citations: 38

    • Year: 2020

  • The impact of a computer-based adult literacy program on literacy and numeracy: Evidence from India

    • Authors: A Deshpande, A Desrochers, C Ksoll, AS Shonchoy

    • Citations: 37

    • Year: 2017

  • Primary, secondary, and tertiary education in Bangladesh: Achievements and challenges

    • Authors: H Kono, Y Sawada, AS Shonchoy

    • Citations: 30

    • Year: 2018

Martin Hudec | Medicine | Best Researcher Award

Published on by Academic Excellence

Dr. Martin Hudec | Medicine | Best Researcher Award

Dr. Martin Hudec, Middle-Slovak Institute of Cardiovascular Diseases (SUSCCH), Slovakia

Dr. Martin Hudec is a distinguished Interventional Cardiologist with extensive experience in cardiovascular diseases. He serves as the Head of the Department of Acute Cardiology at the Middle Slovak Institute of Cardiovascular Diseases, Slovakia. Holding multiple prestigious qualifications, including MUDr., PhD., MBA, MRCPI, and FESC, he specializes in percutaneous myocardial revascularization and advanced cardiac interventions. His research focuses on improving treatment outcomes for chronic heart failure patients. Over the years, Dr. Hudec has contributed significantly to Slovak and European cardiology through leadership roles, including as a board member of the Slovak Society of Cardiology. An active researcher and educator, he serves as an External Cardiology Tutor at the Slovak Medical University. Recognized internationally, he is a Fellow of the European Society of Cardiology (FESC) and a Member of the Editorial Board of SEEJCA. His commitment to excellence in interventional cardiology continues to shape the field.

Professional Profile

Scopus

Orcid

Research for Best Researcher Award – Martin Hudec

Dr. Martin Hudec is highly deserving of the Research for Best Researcher Award due to his extensive academic background, notable clinical experience, and impactful contributions to the field of cardiology. As a highly qualified specialist in Interventional Cardiology, Dr. Hudec has demonstrated an exceptional commitment to both patient care and research. His qualifications include a Doctor of Medicine (MUDr.), PhD, MBA, and various prestigious certifications, including the MRCPI (Royal College of Physicians of Ireland) and FESC (Fellow of the European Society of Cardiology). His research has significantly advanced the understanding of myocardial revascularization, especially its impact on chronic heart failure, as demonstrated in his PhD dissertation at Comenius University.

Throughout his career, Dr. Hudec has held influential roles in numerous cardiology societies, including serving as a board member for the Slovak Society of Cardiology and the Slovak Resuscitation Society. His contributions to education and knowledge dissemination are equally remarkable, as he serves as an external cardiology tutor at the Slovak Medical University and is a member of the editorial board for the South East European Journal of Cardiology. These roles underscore his leadership in shaping the next generation of cardiologists and his commitment to advancing the field.

🎓 Education

Dr. Martin Hudec’s medical journey began at the Jessenius Faculty of Medicine, Comenius University, Slovakia, where he graduated with distinction in 2004. He completed his General Professional Training (GPT) in 2006 and earned Membership of the Royal College of Physicians of Ireland (MRCPI) in 2008. Pursuing excellence, he completed his Specialty Certificate in Cardiology (CCT) in 2011 and later defended his PhD dissertation on percutaneous myocardial revascularization and chronic heart failure in 2018. His academic contributions are further recognized through leadership roles, including Board Member of the Slovak Society of Cardiology and Head of the Interventional Cardiology Committee. As an educator, he plays a vital role as a Cardiology Tutor at Slovak Medical University. His academic journey reflects a deep commitment to advancing cardiovascular medicine through education, research, and clinical expertise, shaping the next generation of cardiologists.

💼 Professional Experience 

Dr. Martin Hudec has a stellar career in interventional cardiology, marked by leadership and clinical excellence. Since 2014, he has served as the Head of the Department of Acute Cardiology at the Middle Slovak Institute of Cardiovascular Diseases. He previously held the role of Head of the Coronary Care Unit (2012-2014) and worked as a Consultant Interventional Cardiologist (2011-present). His expertise was further honed during a Fellowship in Interventional Cardiology at Cork University Hospitals, Ireland (2007-2009), before returning to Slovakia as a Specialist Registrar (2009-2011). Dr. Hudec is an External Cardiology Tutor at Slovak Medical University, actively contributing to medical education. His leadership extends to serving on the board of Slovak and European cardiology committees, ensuring the advancement of interventional techniques and patient care. His dedication has positioned him as a key figure in Slovak cardiovascular medicine.

🏅 Awards and Recognition 

Dr. Martin Hudec is a Fellow of the European Society of Cardiology (FESC), a prestigious recognition of his contributions to cardiovascular medicine. He is a Board Member of the Slovak Society of Cardiology and Head of the Interventional Cardiology Committee, reflecting his leadership in the field. His research excellence was acknowledged with a PhD award for his dissertation on myocardial revascularization in 2018. In 2021, he was appointed as a Member of the Editorial Board of the South East European Journal of Cardiology (SEEJCA). Additionally, he played a pivotal role in Slovak Resuscitation Society and ESC eLearning Platform. His consistent efforts in cardiology research and patient care have earned him widespread respect among peers and international recognition. As an advocate for innovation in cardiovascular treatment, Dr. Hudec continues to shape the future of interventional cardiology through education, research, and practice.

🌍 Research Skills On Medicine

Dr. Martin Hudec specializes in interventional cardiology, focusing on percutaneous myocardial revascularization and chronic heart failure treatment. His research integrates advanced cardiovascular imaging, catheter-based interventions, and hemodynamic analysis to improve patient outcomes. He has contributed to evidence-based clinical guidelines, enhancing treatment strategies for acute coronary syndrome and structural heart diseases. His expertise in endovascular techniques and stent technologies has positioned him at the forefront of modern cardiology. As a board member of cardiology committees, he actively participates in international research collaborations. His research extends to resuscitation science, electrophysiology, and cardiovascular risk assessment, aiming to reduce mortality rates in cardiac patients. Dr. Hudec’s work is frequently published in peer-reviewed medical journals, and he plays a crucial role in mentoring young cardiologists. His ability to merge clinical practice with innovative research has made him a leading authority in interventional cardiology.

📖 Publication Top Notes

  • Title: Early outcomes of the novel Myval THV series compared to SAPIEN THV series and Evolut THV series in individuals with severe aortic stenosis
    Authors: Niels van Royen, Ignacio J. Amat, Martin Hudec, Patrick W. Serruys, Andreas Baumbach, et al.
    Journal: EuroIntervention
    Year: 2025
    Citations: 2

  • Title: LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial
    Authors: Andreas Baumbach, Niels van Royen, Ignacio J. Amat, Ferencz Arnold-Béla, Orsolya Demeterné Kiss, et al.
    Journal: The Lancet
    Year: 2024
    Citations: 16

  • Title: Evaluation of Ultrathin Strut Biodegradable Polymer-Coated Sirolimus-Eluting Stents in an All-Comers Patient Population: 1-Year Results of the S-FLEX Slovakia Registry
    Authors: Martin Hudec, Andrej Kupec, Pavol Gazdic, et al.
    Journal: Anatolian Journal of Cardiology
    Year: 2024

 

Apoorva Ramaswamy | Medicine | Best Researcher Award

Published on by Academic Excellence

Assist. Prof. Dr. Apoorva Ramaswamy | Medicine | Best Researcher Award

 👤Assist. Prof. Dr. Apoorva Ramaswamy, The Ohio State University Wexner Medical Center, United States

Dr. Apoorva Tewari Ramaswamy is an Assistant Professor in the Department of Otolaryngology-Head and Neck Surgery at Ohio State University Wexner Medical Center. With a distinguished academic and clinical career, she has contributed significantly to the fields of laryngology and dysphagia. She earned her medical degree from Yale School of Medicine, where she was honored with the prestigious Samuel Jordan Graham Scholarship. Dr. Ramaswamy is dedicated to advancing patient care, research, and education. She has an active role in the Dysphagia Research Society and serves on multiple committees, focusing on diversity, equity, and inclusion (DEI). Her career is marked by academic excellence, innovative research, and an enduring commitment to improving patient outcomes.

Professional Profile

Scopus

Orcid

🌟  Summary of Suitability for the “Research for Best Researcher Award”

Apoorva Tewari Ramaswamy, MD, is exceptionally well-suited for the “Research for Best Researcher Award” due to her extensive educational background, significant research contributions, leadership in her field, and dedication to advancing medical science. She completed her MD from Yale School of Medicine, where she was awarded the Samuel Jordan Graham Scholarship for demonstrating exceptional academic promise in surgery. Additionally, her recognition as Yale College’s Commencement Flag Bearer highlights her extraordinary contributions not only in academia but also within her community.

Dr. Ramaswamy’s research in the fields of laryngology, dysphagia, and esophagology has been widely recognized. She has published influential work, including studies that explore the role of local IgE in eosinophilic esophagitis, which earned her the AAOA Research Prize. Her research contributions continue through her leadership role in various committees and advisory boards, such as the Dysphagia Research Society and the American Broncho-Esophagological Association.

🎓 Education

Dr. Ramaswamy completed her Doctor of Medicine (MD) at Yale School of Medicine (2011–2015), where she was awarded the Samuel Jordan Graham Scholarship for her final year. She also holds a Bachelor of Science in Molecular, Developmental, and Cellular Biology from Yale College (2007-2011), where she was recognized as the Commencement Flag Bearer for her extraordinary contributions. Early in her education, Dr. Ramaswamy earned the “Triple C” award from the Attorney General of New York State, showcasing her excellence in academics and extracurricular leadership during high school. She also demonstrated athletic prowess, earning Volleyball All League honors and the Sirena Wu Dunn Award. Throughout her education, Dr. Ramaswamy’s academic achievements have consistently set her apart as a leader and innovator.

💼 Professional Experience

Dr. Ramaswamy is currently an Assistant Professor at Ohio State University Wexner Medical Center in the Department of Otolaryngology-Head and Neck Surgery. She completed a fellowship in Laryngology and Bronchoesophagology at UC Davis (2020-2021) and residency in Otolaryngology at New York Presbyterian Hospital (2015-2020), where she received several prestigious awards, including the AAOA Research Prize and the Distinguished House Staff Award. Dr. Ramaswamy also has experience working internationally, with a 2009 internship at PEPFAR-Nigeria and research at Yale on vascular surgery. She has served as a faculty member, mentor, and leader in various medical and academic committees, including the Dysphagia Research Society and the American Broncho-Esophagolical Association, advancing research and educational initiatives in her field.

🏅 Awards and Recognition

Dr. Ramaswamy’s career has been marked by several notable accolades. She was honored with the prestigious James Physician Patient Champion Award in 2024. Throughout her residency, she received multiple awards, such as the AAOA Research Prize and In-Service Prize for her academic excellence. As a faculty member, she has received recognition from various professional societies, including the American Head & Neck Society and the Dysphagia Research Society, where she holds leadership positions. Her achievements in academic surgery were further acknowledged with the Distinguished House Staff Award from Weill Cornell Medical Center in 2019, signifying her contributions to patient care, education, and research.

🌍 Research Skills On Medicine

Dr. Ramaswamy’s research is centered around the treatment of dysphagia, laryngology, and the impacts of esophagology on patients with head and neck cancer. Her research contributions have been presented at prestigious international conferences, with a focus on the intersection of voice and swallowing disorders. Dr. Ramaswamy has also conducted studies on local IgE in eosinophilic esophagitis, which won second place at the 2018 AAOA meeting. As a leader in the Dysphagia Research Society and various academic committees, she has promoted diversity and inclusion within the research community. Her work continues to advance understanding of swallowing disorders and provides practical solutions for patient care.

📖 Publication Top Notes

  1. The efficacy of two commercially available devices for airway foreign body relief: A cadaver study

    • Authors: Ramaswamy, A.; Done, A.; Solis, R.; Srikanth, M.; Olinde, L.; Belafsky, P.
    • Citation: Laryngoscope Investigative Otolaryngology, 2023
    • DOI: 10.1002/lio2.1057

  2. Tongue base augmentation to improve swallow function in a cadaveric model

    • Authors: Ramaswamy, A.T.; Cates, D.; Evangelista, L.; Srikanth, M.; Belafsky, P.
    • Citation: Laryngoscope Investigative Otolaryngology, 2023
    • DOI: 10.1002/lio2.1041

  3. The upper esophageal sphincter: anatomy and physiology

    • Authors: Ramaswamy, A.T.; Martell, P.; Azevedo, R.; Belafsky, P.
    • Citation: Annals of Esophagus, 2022
    • DOI: 10.21037/aoe-21-34

  4. Effects of Pyridostigmine on Esophageal and Pharyngeal Motility in Dysphagic Patients Undergoing High-Resolution Manometry.

  5. Office-Based Procedure Training in Laryngology Fellowship Programs.

    • Authors: Enver N.; Ramaswamy A.; Sulica L.; Pitman MJ
    • Citation: The Laryngoscope, 2020-10
    • DOI: 10.1002/lary.29170
    • PMID: 33043999

  6. How I Do It: A Novel Technique for Endoscopic Placement of Stent in Management of Anterior Glottic Webs.

    • Authors: Enver N.; Ramaswamy A.; Pitman MJ
    • Citation: The Laryngoscope, 2020-09
    • DOI: 10.1002/lary.28965
    • PMID: 32902885

  7. Percutaneous and Open Tracheostomy in Patients with COVID-19: Comparison and Outcomes of an Institutional Series in New York City.

    • Authors: Long SM; Chern A; Feit NZ; Chung S; Ramaswamy AT; Li C; Cooley V; Hill S; Rajwani K; Villena-Vargas J, et al.
    • Citation: Annals of Surgery, 2020-09
    • DOI: 10.1097/sla.0000000000004428
    • PMID: 32889885

  8. Common Otologic Surgical Procedures: Clinical Decision-Making Pearls and the Role of Imaging

    • Authors: Peng, T.; Ramaswamy, A.T.; Kim, A.H.
    • Citation: Neuroimaging Clinics of North America, 2019
    • DOI: 10.1016/j.nic.2018.09.008

  9. Management of Vestibular Schwannomas for the Radiologist

  10. Carcinoma presenting as idiopathic anterior glottic webs: A case series

    • Authors: Ramaswamy, A.T.; Tian, L.; Bock, J.M.; Klein, A.M.; Pitman, M.J.
    • Citation: The Laryngoscope, 2019-09
    • DOI: 10.1002/lary.27711

Sarah Depallens | Medicine | Best Researcher Award

Published on by Academic Excellence

Dr. Sarah Depallens | Medicine | Best Researcher Award

👤 Dr. Sarah Depallens, CAN team Lausanne CHUV, Switzerland

Dr. Sarah Depallens, an accomplished pediatrician born on February 15, 1977, in Lausanne, Switzerland, has made a profound impact in child healthcare. Serving as an Associate Physician at CHUV, she leads the CAN Team (since 2017), the General Pediatrics Outpatient Clinic (since 2023), and the Migratory Pediatrics Consultation (since 2024). Her career spans two decades, marked by expertise in pediatrics, child abuse prevention, and healthcare for vulnerable populations. Dr. Depallens earned her medical degree from the University of Lausanne in 2002 and became a FMH Specialist in Pediatrics in 2011. Her dedication to improving pediatric care is evident in her extensive professional experience, numerous publications, and advocacy for child welfare. Fluent in multiple languages and globally oriented, she is known for her compassionate approach and leadership in addressing healthcare challenges for children and adolescents.

Professional Profile

Orcid

🌟  Suitability for the Research for Best Researcher Award: Dr. Sarah Depallens

Dr. Sarah Depallens exemplifies the qualities of an outstanding researcher and academic leader, making her a highly suitable candidate for the Research for Best Researcher Award. Her extensive professional experience in pediatrics, public health, and migration health reflects a deep commitment to advancing the field and addressing complex societal challenges. As a Médecin Associé and leader of multiple pediatric initiatives at the CHUV (Centre Hospitalier Universitaire Vaudois), Dr. Depallens demonstrates exceptional leadership, innovation, and dedication to improving healthcare for vulnerable populations.

Research Contributions and Professional Impact : Dr. Depallens has significantly contributed to academic research, with an impressive array of publications in high-impact journals addressing critical topics such as child abuse detection, pediatric refugee healthcare, and the psychological impacts of migration on children. Her work combines clinical expertise with public health strategies, as seen in her studies on abusive head trauma, migrant health, and pediatric violence exposure.

🎓 Education 

Dr. Sarah Depallens’ academic journey reflects a commitment to excellence in medicine. She earned her medical degree in 2002 from the University of Lausanne, followed by a doctorate in 2010 with her thesis on healthcare for undocumented children. Dr. Depallens holds the FMH Pediatric Specialist title (2011), reinforcing her expertise in pediatrics. Further enriching her professional profile, she obtained certifications in Public Health (2012) from KMC, India, and medico-legal care for violence survivors (2013). Recognizing the importance of leadership, she completed a CAS in Management for Executives (2017) and a MicroMBA (2024) at CHUV. Her diverse educational experiences include international rotations in Mexico, Cuba, and Switzerland, offering a well-rounded perspective on healthcare challenges. This robust educational foundation underpins her innovative work in pediatric care, advocacy, and research.

💼  Professional Experience 

Dr. Sarah Depallens’ professional journey spans over 20 years, reflecting her expertise in pediatrics and leadership. She began as a Medical Assistant in General Pediatrics (2003-2004) and expanded her experience through roles in Pediatric Surgery, Emergency Medicine, and Neonatology at CHUV and HEL in Lausanne. From 2008 to 2016, she held pivotal roles in multidisciplinary pediatric units, specializing in adolescent health and child abuse prevention. Her international experience includes a year in General Pediatrics at KMC Hospital, India (2011-2012). Since 2017, Dr. Depallens has led the CAN Team at CHUV, addressing child abuse with innovative strategies. She also heads the General Pediatrics Outpatient Clinic and Migratory Pediatrics Consultation, emphasizing healthcare for marginalized children. Her holistic approach and leadership have established her as a pioneer in pediatric medicine.

🏅 Awards and Recognitions

Dr. Sarah Depallens has received several accolades for her contributions to pediatrics. Her pioneering work in child abuse prevention and healthcare for vulnerable populations has earned her recognition both nationally and internationally. She received CHUV’s Excellence in Leadership Award (2020) for her innovative strategies in multidisciplinary pediatric care. Her thesis on undocumented children’s health was awarded the Best Research Thesis by the University of Lausanne (2010). Additionally, her efforts in medico-legal pediatric care earned her the Swiss Pediatric Society Recognition Award (2018). Dr. Depallens has also been lauded for her global outreach, receiving a Certificate of Public Health distinction from KMC, India (2012). Through her publications and advocacy, she continues to inspire advancements in child healthcare, cementing her reputation as a leader in pediatrics.

🌍 Research Skills On Medicine 

Dr. Sarah Depallens’ research skills center on pediatrics, public health, and child abuse prevention. She excels in designing multidisciplinary studies, evidenced by her work on abusive head trauma and the health needs of migrant children. Proficient in quantitative and qualitative methodologies, she collaborates with experts in pediatrics, psychology, and law to develop comprehensive insights into child welfare. Dr. Depallens’ ability to analyze complex data has led to over 20 peer-reviewed publications, addressing topics like pediatric refugees, adolescent health, and medico-legal evaluations. Her research often translates into actionable policies, underscoring her skill in bridging science and practice. Adept in academic writing and presentation, she shares findings at international conferences, fostering global collaboration.

📖 Publication Top Notes

  • Maternal risk factors for infant foster care from birth: a retrospective observational study
    • Authors: Inés Blanco Lara, Antje Horsch, Roger Hilfiker, Sarah Depallens, Vania Sandoz
    • Year: 2025
  • Enfants et adolescent-e-s dans un environnement négligent. La détection précoce comme première réponse à leurs besoins
    • Authors: Cyril Knob, Vania Sandoz, Sarah Depallens
    • Year: 2024
  • Pédiatrie. Consultation en pédiatrie pour les enfants victimes de violence conjugale
    • Authors: Janique Sangsue, Vania Sandoz, Edelweiss Kabwiku, Sarah Depallens
    • Year: 2024
  • Prosecuting cases of abusive head trauma in Switzerland: a descriptive study of the impact of medical documentation and delay of reporting on judicial outcome
    • Authors: Sarah Held, Jean-Jacques Cheseaux, Jean-François Tolsa, Sarah Depallens
    • Year: 2024
  • SECURE: un outil pour évaluer les mineurs victimes de violences conjugales
    • Authors: Janique Sangsue, Sarah Depallens
    • Year: 2023
  • [Assessment of families in situations of forced migration: Transcultural approaches to identifying and supporting psychological suffering].
    • Authors: Javier Sanchis Zozaya, Sydney GAULTIER, Sarah Depallens
    • Year: 2023
  • Paediatric refugees from Ukraine: guidance for health care providers.
    • Authors: Jaeger FN, Christoph Berger, Michael Buettcher, Sarah Depallens, Heininger U, Heller Y, Kohns Vasconcelos M, Leforestier B, Pellaud N, Relly C et al.
    • Year: 2022
  • [Mobbing amongst students: from detection to care: How to work together?]
    • Authors: Redzepi V, Sangsue J, Lugon J, Sarah Depallens
    • Year: 2022
  • Early Diagnosis of Abusive Head Trauma to Avoid Repetitive Shaking Events
    • Authors: Sarah Depallens, Celine Favrod, Philippe Maeder, Diego San Millan, Jean-Jacques Cheseaux
    • Year: 2022
  • Jugendliche mit Migrationshintergrund – Herausforderung für die allgemeine Gesundheit, über welche Hilfsmittel verfügen Kinderärztinnen und Kinderärzte?
    • Authors: Sarah Depallens, Caroline Heiniger, Karine Tzaud
    • Year: 2021